An airway epithelial cell line (CF/T43) was developed by infecting cultured airway epithelial cells from patients with cystic fibrosis (CF) with the pZIPneoSV(X)1/SV40T retrovirus and selecting for G418 resistance and ion transport properties.
Highlights
Cystic fibrosis (CF) is a common generalized disorder of exocrine gland function which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes.
From the laboratory of Anton Jetten, PhD, National Institute of Environmental Health Sciences/NIH.
This product is for sale to Nonprofit customers only. For profit customers, please Contact Us for more information.
Product Type: | Cell Line |
Name: | CF/T43 |
Cell Type: | Airway epithelial cells from cystic fibrosis patients |
Accession ID: | CVCL_HA79 |
Organism: | Human |
Source: | Airways |
Morphology: | Epithelioid |
Biosafety Level: | BL2 |
Growth Conditions: | Ham’s F12 (plus 1 mM glutamine, 14.3 mM Na-bicarbonate, 15 mM Hepes, pH 7.2), penicillin 100 U/ml, streptomycin sulfate 100 ug/ml, gentamycin 50 ug/ml, Insulin 10 ug/ml, hydrocortisone 1 uM, endothelial growth supplement (ECGS) 3.75 ug/ml, epidermal growth factor (EGF) 25 ng/ml, triiodothyronine (T3) 30 nM, transferrin 5 ug/ml, cholera toxin 10ng/ml |
Subculturing: | Doubling time 24-28hrs; Trypsinize at 70-80% confluency and replate at 1:8-10 |
Cryopreservation: | Growth medium plus 20% FBS, 7.5% DMSO |
Storage: | Liquid nitrogen |
Shipped: | Dry Ice |
If you publish research with this product, please let us know so we can cite your paper.